Evolving Cochlear Implant Indications: How Outcomes Drive Candidacy and Governance
An international clinical briefing with Clinical Professor Catherine S. Birman OAM MBBS PhD FRACS (Sydney University, Australia), examining how longitudinal outcomes reshape candidacy criteria, test-battery counselling, and surgical governance.
Candidacy Is an Evolving Process, Not a Static Threshold
Cochlear implant candidacy has never stood still. As surgical techniques, electrode designs, and rehabilitation outcomes improve, the thresholds that define who benefits from implantation expand in both the short and long term.
In this PORA 2026 session, Clinical Professor Catherine Birman reframes cochlear implant indications around outcome-driven evidence — drawing on Australia’s evolving clinical environment as a lens for what otology and audiology programs elsewhere may soon encounter, and detailing the governance frameworks required to protect long-term results.
Contrasting Historical & Modern Indications
Examines why surgical indications exist and how candidacy evaluation has shifted over both short- and long-term horizons in response to observed clinical outcomes.
- How candidacy boundaries evolved in the Australian clinical environment
- Short-term vs. long-term factors shaping individual recommendations
- Why clear indication criteria remain essential as access broadens
Five Questions Addressed in This Briefing
- 01 Contrast cochlear implant candidacy evaluation indications and trace how those criteria have changed over time. Evaluation
- 02 Reframe cochlear implant indications as an evolving process across both the short and long term, identifying the factors that influence clinical recommendations. Process
- 03 Examine why formal indications exist for cochlear implant surgery and what clinical purpose they serve. Rationale
- 04 Consider practical designs for governance in cochlear implant surgery aimed at optimising long-term patient outcomes. Design
- 05 Evaluate governance factors tied directly to sustained cochlear implant outcomes and lifelong post-operative support. Long-Term Care
What Participants Will Learn
Australia’s Evolving CI Landscape
See how cochlear implant indications have changed — and continue to shift — in the Australian environment, offering a preview of transitions likely to occur in your own clinical setting.
The Case for Surgical Governance
Understand why formal governance structures are indispensable as candidacy broadens, aligning institutional accountability with consistent patient outcomes.
Applying Test Batteries to Expectations
Learn how clinicians interpret candidacy test batteries and translate those findings into transparent, evidence-based counselling on expected post-implant outcomes.
Governance for Long-Term Support
Identify the governance factors that protect outcomes beyond surgery, ensuring patients receive structured follow-up and long-term device support.
Clinical Professor Catherine S. Birman
Clinical Professor Catherine S. Birman OAM MBBS PhD FRACS
Ear, Nose & Throat Surgeon · Sydney University, Australia
Clinical Professor Catherine Birman is an Ear, Nose and Throat Surgeon with more than 25 years’ experience treating pediatric and adult hearing loss, having performed over 2,100 cochlear implants in Sydney, Australia. She presents nationally and internationally and has published extensively across otolaryngology and hearing restoration.
As a leading ENT surgeon and researcher, Professor Birman pioneers clinical trials spanning novel cochlear implant devices and inaugural gene therapy studies for hearing loss. Her career encompasses senior leadership roles across major Sydney hospitals, Sydney University, and international advocacy boards, earning prestigious recognition including the Order of Australia Medal (OAM).
| Dimension | Profile Detail | Benchmark |
|---|---|---|
| Qualifications & Honour | MBBS, PhD, FRACS; Order of Australia Medal | OAM |
| Clinical Practice | Pediatric and adult hearing loss management in Sydney, Australia | 25+ Years |
| Surgical Experience | Cochlear implantation procedures performed | 2,100+ Implants |
| Research & Trials | Novel cochlear implant devices & inaugural gene therapy studies for hearing loss | Lead Investigator |
| Institutional Leadership | Major Sydney hospitals, Sydney University, and international advocacy boards | Sydney & Global |